Michael Robertson

  • 10251 Citations
  • 52 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

  • 10251 Citations
  • 52 h-Index
  • 103 Article
  • 6 Review article
  • 2 Comment/debate
  • 1 Letter
2020

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Agrawal, V., Ranganath, P., Ervin, K. D., Schmidt, C. A., Cox, E. A., Nelson, R. P., Schwartz, J. E., Zaid, M. A., Abonour, R., Robertson, M. J., Brinda, B. J., Griffin, S. P., Thakrar, T. C. & Farag, S. S., 2020, (Accepted/In press) In : Bone marrow transplantation.

Research output: Contribution to journalArticle

Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial

Diefenbach, C. S., Hong, F., Ambinder, R. F., Cohen, J. B., Robertson, M. J., David, K. A., Advani, R. H., Fenske, T. S., Barta, S. K., Palmisiano, N. D., Svoboda, J., Morgan, D. S., Karmali, R., Sharon, E., Streicher, H., Kahl, B. S. & Ansell, S. M., Sep 2020, In : The Lancet Haematology. 7, 9, p. e660-e670

Research output: Contribution to journalArticle

2018

A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination with Ofatumumab after Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma

Robertson, M. J., Stamatkin, C. W., Pelloso, D., Weisenbach, J., Prasad, N. K. & Safa, A. R., Jan 1 2018, In : Journal of Immunotherapy. 41, 3, p. 151-157 7 p.

Research output: Contribution to journalArticle

1 Scopus citations
2 Scopus citations
2017

High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

Farag, S. S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

Research output: Contribution to journalArticle

12 Scopus citations
2016

Cognitive and situational precipitants of loneliness among patients with cancer: A qualitative analysis

Adams, R. N., Mosher, C. E., Abonour, R., Robertson, M. J., Champion, V. L. & Kroenke, K., Mar 2016, In : Oncology nursing forum. 43, 2, p. 156-163 8 p.

Research output: Contribution to journalArticle

13 Scopus citations
2015

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Khawaja, M. R., Perkins, S. M., Schwartz, J. E., Robertson, M. J., Kiel, P. J., Sayar, H., Cox, E. A., Vance, G. H., Farag, S. S., Cripe, L. D. & Nelson, R. P., Feb 1 2015, In : American Journal of Hematology. 90, 2, p. 97-99 3 p.

Research output: Contribution to journalArticle

Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial

Goy, A., Kalayoglu Besisik, S., Drach, J., Ramchandren, R., Robertson, M. J., Avivi, I., Rowe, J. M., Herbrecht, R., Van Hoof, A., Zhang, L., Cicero, S., Fu, T. & Witzig, T., Aug 1 2015, In : British journal of haematology. 170, 4, p. 496-503 8 p.

Research output: Contribution to journalArticle

24 Scopus citations
2014

Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant

Tung, C. Y., Lewis, D. E., Han, L., Jaja, M., Yao, S., Li, F., Robertson, M. J., Zhou, B., Sun, J. & Chang, H. C., Jan 1 2014, In : Vaccine. 32, 42, p. 5411-5419 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

Levy, R., Ganjoo, K. N., Leonard, J. P., Vose, J. M., Flinn, I. W., Ambinder, R. F., Connors, J. M., Berinstein, N. L., Belch, A. R., Bartlett, N. L., Nichols, C., Emmanouilides, C. E., Timmerman, J. M., Gregory, S. A., Link, B. K., Inwards, D. J., Freedman, A. S., Matous, J. V., Robertson, M. J., Kunkel, L. A. & 6 others, Ingolia, D. E., Gentles, A. J., Liu, C. L., Tibshirani, R., Alizadeh, A. A. & Denney, D. W., Jun 10 2014, In : Journal of Clinical Oncology. 32, 17, p. 1797-1803 7 p.

Research output: Contribution to journalArticle

46 Scopus citations

Overexpression of type VI collagen in neoplastic lung tissues

Voiles, L., Lewis, D. E., Han, L., Lupov, I. P., Lin, T. L., Robertson, M. J., Petrache, I. & Chang, H. C., Nov 1 2014, In : Oncology reports. 32, 5, p. 1897-1904 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Soypeptide lunasin in cytokine immunotherapy for lymphoma

Chang, H. C., Lewis, D., Tung, C. Y., Han, L., Henriquez, S. M. P., Voiles, L., Lupov, I. P., Pelloso, D., Sinn, A. L., Pollok, K. E., De Lumen, B. O., Li, F., Blum, J. S., Srivastava, S. & Robertson, M. J., Mar 2014, In : Cancer Immunology, Immunotherapy. 63, 3, p. 283-295 13 p.

Research output: Contribution to journalArticle

22 Scopus citations
2013

A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-hodgkin Lymphoma

Robertson, M. J., Kline, J., Struemper, H., Koch, K. M., Bauman, J. W., Gardner, O. S., Murray, S. C., Germaschewski, F., Weisenbach, J., Jonak, Z. & Toso, J. F., Jul 2013, In : Journal of Immunotherapy. 36, 6, p. 331-341 11 p.

Research output: Contribution to journalArticle

15 Scopus citations

Effects of interleukin-18 on natural killer cells: Costimulation of activation through Fc receptors for immunoglobulin

Srivastava, S., Pelloso, D., Feng, H., Voiles, L., Lewis, D., Haskova, Z., Whitacre, M., Trulli, S., Chen, Y. J., Toso, J., Jonak, Z. L., Chang, H. C. & Robertson, M. J., Jun 1 2013, In : Cancer Immunology, Immunotherapy. 62, 6, p. 1073-1082 10 p.

Research output: Contribution to journalArticle

38 Scopus citations

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies

Farag, S. S., Srivastava, S., Messina-Graham, S., Schwartz, J., Robertson, M. J., Abonour, R., Cornetta, K., Wood, L., Secrest, A., Strother, R. M., Jones, D. R. & Broxmeyer, H. E., Apr 1 2013, In : Stem cells and development. 22, 7, p. 1007-1015 9 p.

Research output: Contribution to journalArticle

74 Scopus citations

Primary effusion anaplastic large cell lymphoma in a patient with long-standing dermatitis herpetiformis and celiac disease

Nassiri, M., Robertson, M. J., Hertzberg, L. & Czader, M. B., Jan 1 2013, In : Annals of Hematology. 92, 2, p. 279-281 3 p.

Research output: Contribution to journalLetter

1 Scopus citations
2011

Acquired STAT4 deficiency as a consequence of cancer chemotherapy

Lupov, I. P., Voiles, L., Han, L., Schwartz, A., De La Rosa, M., Oza, K., Pelloso, D., Sahu, R. P., Travers, J. B., Robertson, M. J. & Chang, H. C., Dec 1 2011, In : Blood. 118, 23, p. 6097-6106 10 p.

Research output: Contribution to journalArticle

17 Scopus citations

A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory Non-Hodgkin lymphoma

Srivastava, S., Jones, D., Wood, L. L., Schwartz, J. E., Nelson, R. P., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K., Robertson, M. J. & Farag, S. S., Jul 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 7, p. 987-994 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia

Farag, S. S., Wood, L. L., Schwartz, J. E., Srivastava, S., Nelson, R. P., Robertson, M. J., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K. & Jones, D. R., Apr 2011, In : Leukemia. 25, 4, p. 599-605 7 p.

Research output: Contribution to journalArticle

Open Access
28 Scopus citations

Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation

Rosenbeck, L. L., Kiel, P. J., Kalsekar, I., Vargo, C., Baute, J., Sullivan, C. K., Wood, L., Abdelqader, S., Schwartz, J., Srivastava, S., Abonour, R., Robertson, M. J., Nelson, R. P., Cornetta, K., Fausel, C. A. & Farag, S. S., Jun 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 6, p. 916-922 7 p.

Research output: Contribution to journalArticle

24 Scopus citations
2010

Interleukin-18: Biology and role in the immunotherapy of cancer

Srivastava, S., Salim, N. & Robertson, M. J., Jan 1 2010, In : Current Medicinal Chemistry. 17, 29, p. 3353-3357 5 p.

Research output: Contribution to journalArticle

55 Scopus citations
13 Scopus citations

Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells

Woolfrey, A., Storek, J., Bowyer, S., Nelson, R., Robertson, M. & Wallace, C., Sep 1 2010, In : Pediatric Transplantation. 14, 6, p. E65-E69

Research output: Contribution to journalArticle

1 Scopus citations

The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation

Chang, H. C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A. N., Han, L., Nguyen, E. T., Robertson, M. J., Perumal, N. B., Tepper, R. S., Nutt, S. L. & Kaplan, M. H., Jun 1 2010, In : Nature Immunology. 11, 6, p. 527-534 8 p.

Research output: Contribution to journalArticle

375 Scopus citations
2009

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: Updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Goy, A., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Nasta, S., O'Connor, O. A., Shi, H., Boral, A. L. & Fisher, R. I., 2009, In : Annals of Oncology. 20, 3, p. 520-525 6 p.

Research output: Contribution to journalArticle

258 Scopus citations

Impaired development of human Th1 cells in patients with deficient expression of STAT4

Chang, H. C., Han, L., Goswami, R., Nguyen, E. T., Pelloso, D., Robertson, M. J. & Kaplan, M. H., 2009, In : Blood. 113, 23, p. 5887-5890 4 p.

Research output: Contribution to journalArticle

34 Scopus citations

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma

Freedman, A., Neelapu, S. S., Nichols, C., Robertson, M. J., Djulbegovic, B., Winter, J. N., Bender, J. F., Gold, D. P., Ghalie, R. G., Stewart, M. E., Esquibel, V. & Hamlin, P., Jun 20 2009, In : Journal of Clinical Oncology. 27, 18, p. 3036-3043 8 p.

Research output: Contribution to journalArticle

111 Scopus citations
2008

A dose-escalation study of recombinant human Lnterleukin-18 using two different schedules of administration in patients with cancer

Robertson, M. J., Kirkwood, J. M., Logan, T. F., Koch, K. M., Kathman, S., Kirby, L. C., Bell, W. N., Weisenbach, J., Thurmond, L. M. & Dar, M. M., Jun 1 2008, In : Clinical Cancer Research. 14, 11, p. 3462-3469 8 p.

Research output: Contribution to journalArticle

63 Scopus citations

Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission

Barlow, A., Robertson, M., Doig, A., Stewart, W. & Drummond, M. W., Aug 2008, In : British journal of haematology. 142, 3, p. 327 1 p.

Research output: Contribution to journalArticle

2007

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma

Robertson, M. J., Kahl, B. S., Vose, J. M., De Vos, S., Laughlin, M., Flynn, P. J., Rowland, K., Cruz, J. C., Goldberg, S. L., Musib, L., Darstein, C., Enas, N., Kutok, J. L., Aster, J. C., Neuberg, D., Savage, K. J., LaCasce, A., Thornton, D., Slapak, C. A. & Shipp, M. A., May 1 2007, In : Journal of Clinical Oncology. 25, 13, p. 1741-1746 6 p.

Research output: Contribution to journalArticle

218 Scopus citations
2006

Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.

Robertson, M. J., Mier, J. W., Logan, T., Atkins, M., Koon, H., Koch, K. M., Kathman, S., Pandite, L. N., Oei, C., Kirby, L. C., Jewell, R. C., Bell, W. N., Thurmond, L. M., Weisenbach, J., Roberts, S. & Dar, M. M., Jul 15 2006, In : Clinical cancer research : an official journal of the American Association for Cancer Research. 12, 14 Pt 1, p. 4265-4273 9 p.

Research output: Contribution to journalArticle

98 Scopus citations

Interleukins 18 and 21: Biology, mechanisms of action, toxicity, and clinical activity

Logan, T. F. & Robertson, M. J., Mar 1 2006, In : Current oncology reports. 8, 2, p. 114-119 6 p.

Research output: Contribution to journalReview article

7 Scopus citations

Macrophage activation syndrome and other systemic inflammatory conditions after BMT

Sreedharan, A., Bowyer, S., Wallace, C. A., Robertson, M. J., Schmidt, K., Woolfrey, A. E. & Nelson, R. P., Apr 1 2006, In : Bone Marrow Transplantation. 37, 7, p. 629-634 6 p.

Research output: Contribution to journalReview article

37 Scopus citations

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

Fisher, R. I., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., De Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Stadtmauer, E. A., O'Connor, O. A., Shi, H., Boral, A. L. & Goy, A., Oct 20 2006, In : Journal of Clinical Oncology. 24, 30, p. 4867-4874 8 p.

Research output: Contribution to journalArticle

597 Scopus citations

Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis

Ganjoo, K., An, C., Robertson, M., Gordon, L., Sen, J., Weisenbach, J., Li, S., Weller, E., Orazi, A. & Horning, S., Jun 1 2006, In : Leukemia and Lymphoma. 47, 6, p. 998-1005 8 p.

Research output: Contribution to journalArticle

97 Scopus citations

The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: Implications for the downregulation of CXCL14 in malignancy

Starnes, T., Rasila, K. K., Robertson, M. J., Brahmi, Z., Dahl, R., Christopherson, K. & Hromas, R., Aug 1 2006, In : Experimental Hematology. 34, 8, p. 1101-1105 5 p.

Research output: Contribution to journalArticle

94 Scopus citations
2005

A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: A hoosier oncology group study

Ganjoo, K. N., Robertson, M. J., Fisher, W., Jung, S. H., McClean, J., Huh, S. Y., Bufill, J., Williams, S. & Cripe, L. D., Apr 1 2005, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 28, 2, p. 169-172 4 p.

Research output: Contribution to journalArticle

7 Scopus citations
9 Scopus citations

Impaired interferon-γ production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma

Robertson, M. J., Chang, H. C., Pelloso, D. & Kaplan, M. H., Aug 1 2005, In : Blood. 106, 3, p. 963-970 8 p.

Research output: Contribution to journalArticle

18 Scopus citations

Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression

Robertson, M. J., Schacterle, R. S., Mackin, G. A., Wilson, S. N., Bloomingdale, K. L., Ritz, J. & Komaroff, A. L., Aug 2005, In : Clinical and Experimental Immunology. 141, 2, p. 326-332 7 p.

Research output: Contribution to journalArticle

67 Scopus citations
2004

Immunological Consequences of Interleukin 12 Administration after Autologous Stem Cell Transplantation

Pelloso, D., Cyran, K., Timmons, L., Williams, B. T. & Robertson, M. J., Mar 15 2004, In : Clinical Cancer Research. 10, 6, p. 1935-1942 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease

Younes, A., Pro, B., Robertson, M. J., Flinn, I. W., Romaguera, J. E., Hagemeister, F., Dang, N. H., Fiumara, P., Loyer, E. M., Cabanillas, F. F., McLaughlin, P. W., Rodriguez, M. A. & Samaniego, F., Aug 15 2004, In : Clinical Cancer Research. 10, 16, p. 5432-5438 7 p.

Research output: Contribution to journalArticle

69 Scopus citations
2002

Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis

Starnes, T., Broxmeyer, H. E., Robertson, M. J. & Hromas, R., Jul 15 2002, In : Journal of Immunology. 169, 2, p. 642-646 5 p.

Research output: Contribution to journalArticle

Open Access
201 Scopus citations

Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies

Robertson, M. J., Pelloso, D., Abonour, R., Hromas, R. A., Nelson, R. P., Wood, L. & Cornetta, K., Nov 1 2002, In : Clinical Cancer Research. 8, 11, p. 3383-3393 11 p.

Research output: Contribution to journalArticle

30 Scopus citations

Role of chemokines in the biology of natural killer cells

Robertson, M. J., Feb 1 2002, In : Journal of Leukocyte Biology. 71, 2, p. 173-183 11 p.

Research output: Contribution to journalReview article

348 Scopus citations
2001
Open Access
2 Scopus citations

Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production

Starnes, T., Robertson, M. J., Sledge, G., Kelich, S., Nakshatri, H., Broxmeyer, H. E. & Hromas, R., Oct 15 2001, In : Journal of Immunology. 167, 8, p. 4137-4140 4 p.

Research output: Contribution to journalArticle

Open Access
281 Scopus citations
2000

Activation of primary human chronic lymphocytic leukemia (cll) cells by interleukin-2 (il-2): implications for cancer vaccine development

Robertson, M. J., Ganjoo, K. & Timmons, L., Dec 1 2000, In : Blood. 96, 11 PART II, p. 282b

Research output: Contribution to journalArticle

Efficient retroviral vector - mediated gene transfer into primary human chronic lymphocytic leukemia (CLL) cells after short term in vitro culture

Robertson, M. J., Cripe, L., Ganjoo, K., Timmons, L. & Cornelia, K., Dec 1 2000, In : Blood. 96, 11 PART II, p. 282b

Research output: Contribution to journalArticle